APPLE INC., 10-Q filed on 8/2/2024
Quarterly Report
v3.24.2.u1
Cover Page - shares
shares in Thousands
 9 Months Ended
Jun. 29, 2024
Jul. 19, 2024
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 29, 2024  
Document Transition Report false  
Entity File Number 001-36743  
Entity Registrant Name Apple Inc.  
Entity Incorporation, State or Country Code CA  
Entity Tax Identification Number 94-2404110  
Entity Address, Address Line One One Apple Park Way  
Entity Address, City or Town Cupertino  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95014  
City Area Code 408  
Local Phone Number 996-1010  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   15,204,137
Amendment Flag false  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0000320193  
Current Fiscal Year End Date --09-28  
Common Stock, $0.00001 par value per share    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, $0.00001 par value per share  
Trading Symbol AAPL  
Security Exchange Name NASDAQ  
0.000% Notes due 2025    
Entity Information [Line Items]    
Title of 12(b) Security 0.000% Notes due 2025  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
0.875% Notes due 2025    
Entity Information [Line Items]    
Title of 12(b) Security 0.875% Notes due 2025  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
1.625% Notes due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 1.625% Notes due 2026  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
2.000% Notes due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.000% Notes due 2027  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
1.375% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 1.375% Notes due 2029  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
3.050% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 3.050% Notes due 2029  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
0.500% Notes due 2031    
Entity Information [Line Items]    
Title of 12(b) Security 0.500% Notes due 2031  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
3.600% Notes due 2042    
Entity Information [Line Items]    
Title of 12(b) Security 3.600% Notes due 2042  
No Trading Symbol Flag true  
Security Exchange Name NASDAQ  
v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Net sales $ 85,777 $ 81,797 $ 296,105 $ 293,787
Cost of sales 46,099 45,384 159,301 165,066
Gross margin 39,678 36,413 136,804 128,721
Operating expenses:        
Research and development 8,006 7,442 23,605 22,608
Selling, general and administrative 6,320 5,973 19,574 18,781
Total operating expenses 14,326 13,415 43,179 41,389
Operating income 25,352 22,998 93,625 87,332
Other income/(expense), net 142 (265) 250 (594)
Income before provision for income taxes 25,494 22,733 93,875 86,738
Provision for income taxes 4,046 2,852 14,875 12,699
Net income $ 21,448 $ 19,881 $ 79,000 $ 74,039
Earnings per share:        
Basic (in dollars per share) $ 1.40 $ 1.27 $ 5.13 $ 4.69
Diluted (in dollars per share) $ 1.40 $ 1.26 $ 5.11 $ 4.67
Shares used in computing earnings per share:        
Basic (in shares) 15,287,521 15,697,614 15,401,047 15,792,497
Diluted (in shares) 15,348,175 15,775,021 15,463,175 15,859,263
Products        
Net sales $ 61,564 $ 60,584 $ 224,908 $ 230,901
Cost of sales 39,803 39,136 140,667 146,696
Services        
Net sales 24,213 21,213 71,197 62,886
Cost of sales $ 6,296 $ 6,248 $ 18,634 $ 18,370
v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Statement of Comprehensive Income [Abstract]        
Net income $ 21,448 $ 19,881 $ 79,000 $ 74,039
Other comprehensive income/(loss):        
Change in foreign currency translation, net of tax (73) (385) (87) (494)
Change in unrealized gains/losses on derivative instruments, net of tax:        
Change in fair value of derivative instruments 406 509 331 (492)
Adjustment for net (gains)/losses realized and included in net income (87) 103 (678) (1,854)
Total change in unrealized gains/losses on derivative instruments 319 612 (347) (2,346)
Change in unrealized gains/losses on marketable debt securities, net of tax:        
Change in fair value of marketable debt securities 268 (340) 3,306 1,963
Adjustment for net (gains)/losses realized and included in net income 30 58 164 185
Total change in unrealized gains/losses on marketable debt securities 298 (282) 3,470 2,148
Total other comprehensive income/(loss) 544 (55) 3,036 (692)
Total comprehensive income $ 21,992 $ 19,826 $ 82,036 $ 73,347
v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Jun. 29, 2024
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 25,565 $ 29,965
Marketable securities 36,236 31,590
Accounts receivable, net 22,795 29,508
Vendor non-trade receivables 20,377 31,477
Inventories 6,165 6,331
Other current assets 14,297 14,695
Total current assets 125,435 143,566
Non-current assets:    
Marketable securities 91,240 100,544
Property, plant and equipment, net 44,502 43,715
Other non-current assets 70,435 64,758
Total non-current assets 206,177 209,017
Total assets 331,612 352,583
Current liabilities:    
Accounts payable 47,574 62,611
Other current liabilities 60,889 58,829
Deferred revenue 8,053 8,061
Commercial paper 2,994 5,985
Term debt 12,114 9,822
Total current liabilities 131,624 145,308
Non-current liabilities:    
Term debt 86,196 95,281
Other non-current liabilities 47,084 49,848
Total non-current liabilities 133,280 145,129
Total liabilities 264,904 290,437
Commitments and contingencies
Common stock, shares outstanding (in shares) 15,222,259 15,550,061
Common stock, shares issued (in shares) 15,222,259 15,550,061
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,222,259 and 15,550,061 shares issued and outstanding, respectively $ 79,850 $ 73,812
Accumulated deficit (4,726) (214)
Accumulated other comprehensive loss (8,416) (11,452)
Total shareholders’ equity 66,708 62,146
Total liabilities and shareholders’ equity $ 331,612 $ 352,583
v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Jun. 29, 2024
Sep. 30, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 50,400,000,000 50,400,000,000
Common stock, shares issued (in shares) 15,222,259,000 15,550,061,000
Common stock, shares outstanding (in shares) 15,222,259,000 15,550,061,000
v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common stock and additional paid-in capital
Retained earnings/(Accumulated deficit)
Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 24, 2022 $ 50,672 $ 64,849 $ (3,068) $ (11,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   690    
Common stock withheld related to net share settlement of equity awards   (3,310) (1,988)  
Share-based compensation   8,438    
Net income 74,039   74,039  
Dividends and dividend equivalents declared     (11,207)  
Common stock repurchased     (56,368)  
Other comprehensive income/(loss) (692)     (692)
Ending balances at Jul. 01, 2023 $ 60,274 70,667 1,408 (11,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.70      
Beginning balances at Apr. 01, 2023 $ 62,158 69,568 4,336 (11,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   0    
Common stock withheld related to net share settlement of equity awards   (1,595) (858)  
Share-based compensation   2,694    
Net income 19,881   19,881  
Dividends and dividend equivalents declared     (3,811)  
Common stock repurchased     (18,140)  
Other comprehensive income/(loss) (55)     (55)
Ending balances at Jul. 01, 2023 $ 60,274 70,667 1,408 (11,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.24      
Beginning balances at Sep. 30, 2023 $ 62,146 73,812 (214) (11,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   752    
Common stock withheld related to net share settlement of equity awards   (3,802) (1,517)  
Share-based compensation   9,088    
Net income 79,000   79,000  
Dividends and dividend equivalents declared     (11,384)  
Common stock repurchased (70,000)   (70,611)  
Other comprehensive income/(loss) 3,036     3,036
Ending balances at Jun. 29, 2024 $ 66,708 79,850 (4,726) (8,416)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.73      
Beginning balances at Mar. 30, 2024 $ 74,194 78,815 4,339 (8,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   0    
Common stock withheld related to net share settlement of equity awards   (1,920) (428)  
Share-based compensation   2,955    
Net income 21,448   21,448  
Dividends and dividend equivalents declared     (3,864)  
Common stock repurchased     (26,221)  
Other comprehensive income/(loss) 544     544
Ending balances at Jun. 29, 2024 $ 66,708 $ 79,850 $ (4,726) $ (8,416)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.25      
v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Statement of Cash Flows [Abstract]    
Cash, cash equivalents and restricted cash, beginning balances $ 30,737 $ 24,977
Operating activities:    
Net income 79,000 74,039
Adjustments to reconcile net income to cash generated by operating activities:    
Depreciation and amortization 8,534 8,866
Share-based compensation expense 8,830 8,208
Other (1,964) (1,651)
Changes in operating assets and liabilities:    
Accounts receivable, net 6,697 7,609
Vendor non-trade receivables 11,100 13,111
Inventories 41 (2,570)
Other current and non-current assets (5,626) (4,863)
Accounts payable (15,171) (16,790)
Other current and non-current liabilities 2 2,986
Cash generated by operating activities 91,443 88,945
Investing activities:    
Purchases of marketable securities (38,074) (20,956)
Proceeds from maturities of marketable securities 39,838 27,857
Proceeds from sales of marketable securities 7,382 3,959
Payments for acquisition of property, plant and equipment (6,539) (8,796)
Other (1,117) (753)
Cash generated by investing activities 1,490 1,311
Financing activities:    
Payments for taxes related to net share settlement of equity awards (5,163) (5,119)
Payments for dividends and dividend equivalents (11,430) (11,267)
Repurchases of common stock (69,866) (56,547)
Proceeds from issuance of term debt, net 0 5,228
Repayments of term debt (7,400) (11,151)
Repayments of commercial paper, net (2,985) (5,971)
Other (191) (508)
Cash used in financing activities (97,035) (85,335)
Increase/(Decrease) in cash, cash equivalents and restricted cash (4,102) 4,921
Cash, cash equivalents and restricted cash, ending balances 26,635 29,898
Supplemental cash flow disclosure:    
Cash paid for income taxes, net $ 19,230 $ 7,020
v3.24.2.u1
Summary of Significant Accounting Policies
 9 Months Ended
Jun. 29, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”).
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
v3.24.2.u1
Revenue
 9 Months Ended
Jun. 29, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Net sales disaggregated by significant products and services for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 were as follows (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
iPhone®
$39,296 $39,669 $154,961 $156,778 
Mac®
7,009 6,840 22,240 21,743 
iPad®
7,162 5,791 19,744 21,857 
Wearables, Home and Accessories8,097 8,284 27,963 30,523 
Services24,213 21,213 71,197 62,886 
Total net sales$85,777 $81,797 $296,105 $293,787 
Total net sales include $3.4 billion of revenue recognized in the three months ended June 29, 2024 that was included in deferred revenue as of March 30, 2024, $3.3 billion of revenue recognized in the three months ended July 1, 2023 that was included in deferred revenue as of April 1, 2023, $6.5 billion of revenue recognized in the nine months ended June 29, 2024 that was included in deferred revenue as of September 30, 2023, and $7.0 billion of revenue recognized in the nine months ended July 1, 2023 that was included in deferred revenue as of September 24, 2022.
The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 11, “Segment Information and Geographic Data” for the three- and nine-month periods ended June 29, 2024 and July 1, 2023, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
As of June 29, 2024 and September 30, 2023, the Company had total deferred revenue of $12.5 billion and $12.1 billion, respectively. As of June 29, 2024, the Company expects 64% of total deferred revenue to be realized in less than a year, 25% within one-to-two years, 9% within two-to-three years and 2% in greater than three years.
v3.24.2.u1
Earnings Per Share
 9 Months Ended
Jun. 29, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (net income in millions and shares in thousands):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Numerator:
Net income$21,448 $19,881 $79,000 $74,039 
Denominator:
Weighted-average basic shares outstanding15,287,521 15,697,614 15,401,047 15,792,497 
Effect of dilutive share-based awards
60,654 77,407 62,128 66,766 
Weighted-average diluted shares15,348,175 15,775,021 15,463,175 15,859,263 
Basic earnings per share$1.40 $1.27 $5.13 $4.69 
Diluted earnings per share$1.40 $1.26 $5.11 $4.67 
Approximately 32 million restricted stock units (“RSUs”) were excluded from the computation of diluted earnings per share for the nine months ended July 1, 2023 because their effect would have been antidilutive.
v3.24.2.u1
Financial Instruments
 9 Months Ended
Jun. 29, 2024
Financial Instruments [Abstract]  
Financial Instruments Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of June 29, 2024 and September 30, 2023 (in millions):
June 29, 2024
Adjusted
Cost		Unrealized
Gains		Unrealized
Losses		Fair
Value		Cash and
Cash
Equivalents		Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$22,866 $— $— $22,866 $22,866 $— $— 
Level 1:
Money market funds1,648 — — 1,648 1,648 — — 
Mutual funds
493 76 (7)562 — 562 — 
Subtotal2,141 76 (7)2,210 1,648 562 — 
Level 2 (1):
U.S. Treasury securities16,298 3 (855)15,446 138 4,649 10,659 
U.S. agency securities5,500 — (418)5,082 73 518 4,491 
Non-U.S. government securities17,560 31 (680)16,911 — 11,592 5,319 
Certificates of deposit and time deposits1,337 — — 1,337 838 492 7 
Commercial paper1,346 — — 1,346 2 1,344 — 
Corporate debt securities68,194 83 (3,350)64,927 — 15,489 49,438 
Municipal securities480 — (13)467 — 197 270 
Mortgage- and asset-backed securities24,508 27 (2,086)22,449 — 1,393 21,056 
Subtotal135,223 144 (7,402)127,965 1,051 35,674 91,240 
Total (2)
$160,230 $220 $(7,409)$153,041 $25,565 $36,236 $91,240 
September 30, 2023
Adjusted
Cost		Unrealized
Gains		Unrealized
Losses		Fair
Value		Cash and
Cash
Equivalents		Current
Marketable
Securities		Non-Current
Marketable
Securities
Cash$28,359 $— $— $28,359 $28,359 $— $— 
Level 1:
Money market funds481 — — 481 481 — — 
Mutual funds and equity securities
442 12 (26)428 — 428 — 
Subtotal923 12 (26)909 481 428 — 
Level 2 (1):
U.S. Treasury securities19,406 — (1,292)18,114 35 5,468 12,611 
U.S. agency securities5,736 — (600)5,136 36 271 4,829 
Non-U.S. government securities17,533 6 (1,048)16,491 — 11,332 5,159 
Certificates of deposit and time deposits1,354 — — 1,354 1,034 320 — 
Commercial paper608 — — 608 — 608 — 
Corporate debt securities76,840 6 (5,956)70,890 20 12,627 58,243 
Municipal securities628 — (26)602 — 192 410 
Mortgage- and asset-backed securities22,365 6 (2,735)19,636 — 344 19,292 
Subtotal144,470 18 (11,657)132,831 1,125 31,162 100,544 
Total (2)
$173,752 $30 $(11,683)$162,099 $29,965 $31,590 $100,544 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
(2)As of June 29, 2024 and September 30, 2023, total marketable securities included $14.1 billion and $13.8 billion, respectively, that were restricted from general use, related to the State Aid Decision (refer to Note 6, “Income Taxes”) and other agreements.
The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of June 29, 2024 (in millions):
Due after 1 year through 5 years$64,209 
Due after 5 years through 10 years8,660 
Due after 10 years18,371 
Total fair value$91,240 
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.
Foreign Exchange Rate Risk
To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of June 29, 2024, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 18 years.
The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges.
The notional amounts of the Company’s outstanding derivative instruments as of June 29, 2024 and September 30, 2023 were as follows (in millions):
June 29,
2024		September 30,
2023
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$65,542 $74,730 
Interest rate contracts$13,875 $19,375 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$97,136 $104,777 
The carrying amounts of the Company’s hedged items in fair value hedges as of June 29, 2024 and September 30, 2023 were as follows (in millions):
June 29,
2024		September 30,
2023
Hedged assets/(liabilities):
Current and non-current marketable securities$15,007 $14,433 
Current and non-current term debt$(13,096)$(18,247)
Accounts Receivable
Trade Receivables
The Company’s third-party cellular network carriers accounted for 32% and 41% of total trade receivables as of June 29, 2024 and September 30, 2023, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk.
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of June 29, 2024, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 46% and 18%. As of September 30, 2023, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 48% and 23%.
v3.24.2.u1
Condensed Consolidated Financial Statement Details
 9 Months Ended
Jun. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Consolidated Financial Statement Details Condensed Consolidated Financial Statement Details
The following table shows the Company’s condensed consolidated financial statement details as of June 29, 2024 and September 30, 2023 (in millions):
Property, Plant and Equipment, Net
June 29,
2024		September 30,
2023
Gross property, plant and equipment$117,129 $114,599 
Accumulated depreciation
(72,627)(70,884)
Total property, plant and equipment, net$44,502 $43,715 
v3.24.2.u1
Income Taxes
 9 Months Ended
Jun. 29, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
European Commission State Aid Decision
On August 30, 2016, the European Commission (the “Commission”) announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (the “State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward. The Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (the “General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (the “ECJ”) and a hearing was held on May 23, 2023. A decision from the ECJ is expected in the fourth quarter of 2024. The Company believes it would be eligible to claim a U.S. foreign tax credit for a portion of any incremental Irish corporate income taxes potentially due related to the State Aid Decision.
v3.24.2.u1
Debt
 9 Months Ended
Jun. 29, 2024
Debt Disclosure [Abstract]  
Debt Debt
Commercial Paper
The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of June 29, 2024 and September 30, 2023, the Company had $3.0 billion and $6.0 billion of commercial paper outstanding, respectively. The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the nine months ended June 29, 2024 and July 1, 2023 (in millions):
Nine Months Ended
June 29,
2024		July 1,
2023
Maturities 90 days or less:
Repayments of commercial paper, net$(2,985)$(3,326)
Maturities greater than 90 days:
Repayments of commercial paper— (2,645)
Total repayments of commercial paper, net$(2,985)$(5,971)
Term Debt
As of June 29, 2024 and September 30, 2023, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $98.3 billion and $105.1 billion, respectively (collectively the “Notes”). As of June 29, 2024 and September 30, 2023, the fair value of the Company’s Notes, based on Level 2 inputs, was $86.2 billion and $90.8 billion, respectively.
v3.24.2.u1
Shareholders' Equity
 9 Months Ended
Jun. 29, 2024
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
Share Repurchase Program
During the nine months ended June 29, 2024, the Company repurchased 387 million shares of its common stock for $70.0 billion. The Company’s share repurchase programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
v3.24.2.u1
Share-Based Compensation
 9 Months Ended
Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
Restricted Stock Units
A summary of the Company’s RSU activity and related information for the nine months ended June 29, 2024 is as follows:
Number of
RSUs
(in thousands)
Weighted-Average
Grant Date Fair
Value Per RSU
Aggregate
Fair Value
(in millions)
Balance as of September 30, 2023180,247 $135.91 
RSUs granted78,276 $172.26 
RSUs vested(83,842)$126.47 
RSUs canceled(8,258)$137.85 
Balance as of June 29, 2024166,423 $157.66 $35,052 
The fair value as of the respective vesting dates of RSUs was $6.4 billion and $15.0 billion for the three- and nine-month periods ended June 29, 2024, respectively, and was $7.0 billion and $14.9 billion for the three- and nine-month periods ended July 1, 2023, respectively.
Share-Based Compensation
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Share-based compensation expense$2,869 $2,617 $8,830 $8,208 
Income tax benefit related to share-based compensation expense$(764)$(993)$(2,662)$(2,791)
As of June 29, 2024, the total unrecognized compensation cost related to outstanding RSUs was $21.9 billion, which the Company expects to recognize over a weighted-average period of 2.6 years.
v3.24.2.u1
Contingencies
 9 Months Ended
Jun. 29, 2024
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.
v3.24.2.u1
Segment Information and Geographic Data
 9 Months Ended
Jun. 29, 2024
Segment Reporting [Abstract]  
Segment Information and Geographic Data Segment Information and Geographic Data
The following table shows information by reportable segment for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Americas:
Net sales$37,678 $35,383 $125,381 $122,445 
Operating income$15,209 $13,117 $50,640 $44,908 
Europe:
Net sales$21,884 $20,205 $76,404 $71,831 
Operating income$9,170 $7,995 $31,872 $27,380 
Greater China:
Net sales$14,728 $15,758 $51,919 $57,475 
Operating income$5,562 $6,207 $20,884 $24,175 
Japan:
Net sales$5,097 $4,821 $19,126 $18,752 
Operating income$2,544 $2,443 $9,498 $9,073 
Rest of Asia Pacific:
Net sales$6,390 $5,630 $23,275 $23,284 
Operating income$2,610 $2,328 $9,995 $9,447 
A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 is as follows (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Segment operating income$35,095 $32,090 $122,889 $114,983 
Research and development expense(8,006)(7,442)(23,605)(22,608)
Other corporate expenses, net(1,737)(1,650)(5,659)(5,043)
Total operating income$25,352 $22,998 $93,625 $87,332 
v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Pay vs Performance Disclosure        
Net income $ 21,448 $ 19,881 $ 79,000 $ 74,039
v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended
Jun. 29, 2024
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Tim Cook [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 24, 2024, Tim Cook, the Company’s Chief Executive Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the sale, subject to certain price limits, of shares vesting during the duration of the plan pursuant to certain equity awards granted to Mr. Cook, excluding shares withheld by the Company to satisfy income tax withholding and remittance obligations. Mr. Cook’s plan will expire on May 24, 2026, subject to early termination in accordance with the terms of the plan.
Name Tim Cook
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 24, 2024
Arrangement Duration 730 days
v3.24.2.u1
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Jun. 29, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Preparation
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”).
Fiscal Period
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
v3.24.2.u1
Revenue (Tables)
 9 Months Ended
Jun. 29, 2024
Revenue from Contract with Customer [Abstract]  
Net Sales Disaggregated by Significant Products and Services
Net sales disaggregated by significant products and services for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 were as follows (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
iPhone®
$39,296 $39,669 $154,961 $156,778 
Mac®
7,009 6,840 22,240 21,743 
iPad®
7,162 5,791 19,744 21,857 
Wearables, Home and Accessories8,097 8,284 27,963 30,523 
Services24,213 21,213 71,197 62,886 
Total net sales$85,777 $81,797 $296,105 $293,787 
v3.24.2.u1
Earnings Per Share (Tables)
 9 Months Ended
Jun. 29, 2024
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (net income in millions and shares in thousands):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Numerator:
Net income$21,448 $19,881 $79,000 $74,039 
Denominator:
Weighted-average basic shares outstanding15,287,521 15,697,614 15,401,047 15,792,497 
Effect of dilutive share-based awards
60,654 77,407 62,128 66,766 
Weighted-average diluted shares15,348,175 15,775,021 15,463,175 15,859,263 
Basic earnings per share$1.40 $1.27 $5.13 $4.69 
Diluted earnings per share$1.40 $1.26 $5.11 $4.67 
v3.24.2.u1
Financial Instruments (Tables)
 9 Months Ended
Jun. 29, 2024
Financial Instruments [Abstract]  
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of June 29, 2024 and September 30, 2023 (in millions):
June 29, 2024
Adjusted
Cost		Unrealized
Gains		Unrealized
Losses		Fair
Value		Cash and
Cash
Equivalents		Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$22,866 $— $— $22,866 $22,866 $— $— 
Level 1:
Money market funds1,648 — — 1,648 1,648 — — 
Mutual funds
493 76 (7)562 — 562 — 
Subtotal2,141 76 (7)2,210 1,648 562 — 
Level 2 (1):
U.S. Treasury securities16,298 3 (855)15,446 138 4,649 10,659 
U.S. agency securities5,500 — (418)5,082 73 518 4,491 
Non-U.S. government securities17,560 31 (680)16,911 — 11,592 5,319 
Certificates of deposit and time deposits1,337 — — 1,337 838 492 7 
Commercial paper1,346 — — 1,346 2 1,344 — 
Corporate debt securities68,194 83 (3,350)64,927 — 15,489 49,438 
Municipal securities480 — (13)467 — 197 270 
Mortgage- and asset-backed securities24,508 27 (2,086)22,449 — 1,393 21,056 
Subtotal135,223 144 (7,402)127,965 1,051 35,674 91,240 
Total (2)
$160,230 $220 $(7,409)$153,041 $25,565 $36,236 $91,240 
September 30, 2023
Adjusted
Cost		Unrealized
Gains		Unrealized
Losses		Fair
Value		Cash and
Cash
Equivalents		Current
Marketable
Securities		Non-Current
Marketable
Securities
Cash$28,359 $— $— $28,359 $28,359 $— $— 
Level 1:
Money market funds481 — — 481 481 — — 
Mutual funds and equity securities
442 12 (26)428 — 428 — 
Subtotal923 12 (26)909 481 428 — 
Level 2 (1):
U.S. Treasury securities19,406 — (1,292)18,114 35 5,468 12,611 
U.S. agency securities5,736 — (600)5,136 36 271 4,829 
Non-U.S. government securities17,533 6 (1,048)16,491 — 11,332 5,159 
Certificates of deposit and time deposits1,354 — — 1,354 1,034 320 — 
Commercial paper608 — — 608 — 608 — 
Corporate debt securities76,840 6 (5,956)70,890 20 12,627 58,243 
Municipal securities628 — (26)602 — 192 410 
Mortgage- and asset-backed securities22,365 6 (2,735)19,636 — 344 19,292 
Subtotal144,470 18 (11,657)132,831 1,125 31,162 100,544 
Total (2)
$173,752 $30 $(11,683)$162,099 $29,965 $31,590 $100,544 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
(2)As of June 29, 2024 and September 30, 2023, total marketable securities included $14.1 billion and $13.8 billion, respectively, that were restricted from general use, related to the State Aid Decision (refer to Note 6, “Income Taxes”) and other agreements.
Non-Current Marketable Debt Securities by Contractual Maturity
The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of June 29, 2024 (in millions):
Due after 1 year through 5 years$64,209 
Due after 5 years through 10 years8,660 
Due after 10 years18,371 
Total fair value$91,240 
Notional Amounts of Outstanding Derivative Instruments
The notional amounts of the Company’s outstanding derivative instruments as of June 29, 2024 and September 30, 2023 were as follows (in millions):
June 29,
2024		September 30,
2023
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$65,542 $74,730 
Interest rate contracts$13,875 $19,375 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$97,136 $104,777 
Carrying Amounts of Hedged Items in Fair Value Hedges
The carrying amounts of the Company’s hedged items in fair value hedges as of June 29, 2024 and September 30, 2023 were as follows (in millions):
June 29,
2024		September 30,
2023
Hedged assets/(liabilities):
Current and non-current marketable securities$15,007 $14,433 
Current and non-current term debt$(13,096)$(18,247)
v3.24.2.u1
Condensed Consolidated Financial Statement Details (Tables)
 9 Months Ended
Jun. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Property, Plant and Equipment, Net
The following table shows the Company’s condensed consolidated financial statement details as of June 29, 2024 and September 30, 2023 (in millions):
Property, Plant and Equipment, Net
June 29,
2024		September 30,
2023
Gross property, plant and equipment$117,129 $114,599 
Accumulated depreciation
(72,627)(70,884)
Total property, plant and equipment, net$44,502 $43,715 
v3.24.2.u1
Debt (Tables)
 9 Months Ended
Jun. 29, 2024
Debt Disclosure [Abstract]  
Summary of Cash Flows Associated with the Issuance and Maturities of Commercial Paper The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the nine months ended June 29, 2024 and July 1, 2023 (in millions):
Nine Months Ended
June 29,
2024		July 1,
2023
Maturities 90 days or less:
Repayments of commercial paper, net$(2,985)$(3,326)
Maturities greater than 90 days:
Repayments of commercial paper— (2,645)
Total repayments of commercial paper, net$(2,985)$(5,971)
v3.24.2.u1
Share-Based Compensation (Tables)
 9 Months Ended
Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Unit Activity
A summary of the Company’s RSU activity and related information for the nine months ended June 29, 2024 is as follows:
Number of
RSUs
(in thousands)
Weighted-Average
Grant Date Fair
Value Per RSU
Aggregate
Fair Value
(in millions)
Balance as of September 30, 2023180,247 $135.91 
RSUs granted78,276 $172.26 
RSUs vested(83,842)$126.47 
RSUs canceled(8,258)$137.85 
Balance as of June 29, 2024166,423 $157.66 $35,052 
Summary of Share-Based Compensation Expense and the Related Income Tax Benefit
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Share-based compensation expense$2,869 $2,617 $8,830 $8,208 
Income tax benefit related to share-based compensation expense$(764)$(993)$(2,662)$(2,791)
v3.24.2.u1
Segment Information and Geographic Data (Tables)
 9 Months Ended
Jun. 29, 2024
Segment Reporting [Abstract]  
Information by Reportable Segment
The following table shows information by reportable segment for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Americas:
Net sales$37,678 $35,383 $125,381 $122,445 
Operating income$15,209 $13,117 $50,640 $44,908 
Europe:
Net sales$21,884 $20,205 $76,404 $71,831 
Operating income$9,170 $7,995 $31,872 $27,380 
Greater China:
Net sales$14,728 $15,758 $51,919 $57,475 
Operating income$5,562 $6,207 $20,884 $24,175 
Japan:
Net sales$5,097 $4,821 $19,126 $18,752 
Operating income$2,544 $2,443 $9,498 $9,073 
Rest of Asia Pacific:
Net sales$6,390 $5,630 $23,275 $23,284 
Operating income$2,610 $2,328 $9,995 $9,447 
Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations
A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 is as follows (in millions):
Three Months EndedNine Months Ended
June 29,
2024		July 1,
2023		June 29,
2024		July 1,
2023
Segment operating income$35,095 $32,090 $122,889 $114,983 
Research and development expense(8,006)(7,442)(23,605)(22,608)
Other corporate expenses, net(1,737)(1,650)(5,659)(5,043)
Total operating income$25,352 $22,998 $93,625 $87,332 
v3.24.2.u1
Revenue - Net Sales Disaggregated by Significant Products and Services (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Disaggregation of Revenue [Line Items]        
Net sales $ 85,777 $ 81,797 $ 296,105 $ 293,787
iPhone        
Disaggregation of Revenue [Line Items]        
Net sales 39,296 39,669 154,961 156,778
Mac        
Disaggregation of Revenue [Line Items]        
Net sales 7,009 6,840 22,240 21,743
iPad        
Disaggregation of Revenue [Line Items]        
Net sales 7,162 5,791 19,744 21,857
Wearables, Home and Accessories        
Disaggregation of Revenue [Line Items]        
Net sales 8,097 8,284 27,963 30,523
Services        
Disaggregation of Revenue [Line Items]        
Net sales $ 24,213 $ 21,213 $ 71,197 $ 62,886
v3.24.2.u1
Revenue - Additional Information (Details) - USD ($)
$ in Billions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]          
Revenue recognized that was included in deferred revenue at the beginning of the period $ 3.4 $ 3.3 $ 6.5 $ 7.0  
Total deferred revenue $ 12.5   $ 12.5   $ 12.1
v3.24.2.u1
Revenue - Deferred Revenue, Expected Timing of Realization (Details)
Jun. 29, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-06-30  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 64.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-06-29  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 25.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-06-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 9.00%
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-06-27  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 2.00%
Deferred revenue, expected timing of realization, period 1 year
v3.24.2.u1
Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Numerator:        
Net income $ 21,448 $ 19,881 $ 79,000 $ 74,039
Denominator:        
Weighted-average basic shares outstanding (in shares) 15,287,521 15,697,614 15,401,047 15,792,497
Effect of dilutive share-based awards (in shares) 60,654 77,407 62,128 66,766
Weighted-average diluted shares (in shares) 15,348,175 15,775,021 15,463,175 15,859,263
Basic earnings per share (in dollars per share) $ 1.40 $ 1.27 $ 5.13 $ 4.69
Diluted earnings per share (in dollars per share) $ 1.40 $ 1.26 $ 5.11 $ 4.67
v3.24.2.u1
Earnings Per Share - Additional Information (Details)
shares in Millions
 9 Months Ended
Jul. 01, 2023
shares
Restricted stock units  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Restricted stock units excluded from the computation of diluted earnings per share because their effect would have been antidilutive (in shares) 32
v3.24.2.u1
Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jun. 29, 2024
Sep. 30, 2023
Marketable Securities [Line Items]    
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost $ 160,230 $ 173,752
Cash Equivalents and Marketable Securities, Unrealized Gains 220 30
Cash Equivalents and Marketable Securities, Unrealized Losses (7,409) (11,683)
Cash, Cash Equivalents and Marketable Securities, Fair Value 153,041 162,099
Cash and Cash Equivalents 25,565 29,965
Current Marketable Securities 36,236 31,590
Non-Current Marketable Securities 91,240 100,544
Total marketable securities that were restricted from general use 14,100 13,800
Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 2,141 923
Marketable Securities, Equity, Unrealized Gains 76 12
Marketable Securities, Equity, Unrealized Losses (7) (26)
Marketable Securities, Equity, Fair Value 2,210 909
Cash and Cash Equivalents 1,648 481
Current Marketable Securities 562 428
Non-Current Marketable Securities 0 0
Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 135,223 144,470
Marketable Securities, Debt, Unrealized Gains 144 18
Marketable Securities, Debt, Unrealized Losses (7,402) (11,657)
Marketable Securities, Debt, Fair Value 127,965 132,831
Cash and Cash Equivalents 1,051 1,125
Current Marketable Securities 35,674 31,162
Non-Current Marketable Securities 91,240 100,544
Cash    
Marketable Securities [Line Items]    
Cash 22,866 28,359
Cash and Cash Equivalents 22,866 28,359
Current Marketable Securities 0 0
Non-Current Marketable Securities 0 0
Money market funds | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 1,648 481
Marketable Securities, Equity, Unrealized Gains 0 0
Marketable Securities, Equity, Unrealized Losses 0 0
Marketable Securities, Equity, Fair Value 1,648 481
Cash and Cash Equivalents 1,648 481
Current Marketable Securities 0 0
Non-Current Marketable Securities 0 0
Mutual funds | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost 493  
Marketable Securities, Equity, Unrealized Gains 76  
Marketable Securities, Equity, Unrealized Losses (7)  
Marketable Securities, Equity, Fair Value 562  
Cash and Cash Equivalents 0  
Current Marketable Securities 562  
Non-Current Marketable Securities 0  
Mutual funds and equity securities | Level 1    
Marketable Securities [Line Items]    
Marketable Securities, Equity, Adjusted Cost   442
Marketable Securities, Equity, Unrealized Gains   12
Marketable Securities, Equity, Unrealized Losses   (26)
Marketable Securities, Equity, Fair Value   428
Cash and Cash Equivalents   0
Current Marketable Securities   428
Non-Current Marketable Securities   0
U.S. Treasury securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 16,298 19,406
Marketable Securities, Debt, Unrealized Gains 3 0
Marketable Securities, Debt, Unrealized Losses (855) (1,292)
Marketable Securities, Debt, Fair Value 15,446 18,114
Cash and Cash Equivalents 138 35
Current Marketable Securities 4,649 5,468
Non-Current Marketable Securities 10,659 12,611
U.S. agency securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 5,500 5,736
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses (418) (600)
Marketable Securities, Debt, Fair Value 5,082 5,136
Cash and Cash Equivalents 73 36
Current Marketable Securities 518 271
Non-Current Marketable Securities 4,491 4,829
Non-U.S. government securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 17,560 17,533
Marketable Securities, Debt, Unrealized Gains 31 6
Marketable Securities, Debt, Unrealized Losses (680) (1,048)
Marketable Securities, Debt, Fair Value 16,911 16,491
Cash and Cash Equivalents 0 0
Current Marketable Securities 11,592 11,332
Non-Current Marketable Securities 5,319 5,159
Certificates of deposit and time deposits | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 1,337 1,354
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses 0 0
Marketable Securities, Debt, Fair Value 1,337 1,354
Cash and Cash Equivalents 838 1,034
Current Marketable Securities 492 320
Non-Current Marketable Securities 7 0
Commercial paper | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 1,346 608
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses 0 0
Marketable Securities, Debt, Fair Value 1,346 608
Cash and Cash Equivalents 2 0
Current Marketable Securities 1,344 608
Non-Current Marketable Securities 0 0
Corporate debt securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 68,194 76,840
Marketable Securities, Debt, Unrealized Gains 83 6
Marketable Securities, Debt, Unrealized Losses (3,350) (5,956)
Marketable Securities, Debt, Fair Value 64,927 70,890
Cash and Cash Equivalents 0 20
Current Marketable Securities 15,489 12,627
Non-Current Marketable Securities 49,438 58,243
Municipal securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 480 628
Marketable Securities, Debt, Unrealized Gains 0 0
Marketable Securities, Debt, Unrealized Losses (13) (26)
Marketable Securities, Debt, Fair Value 467 602
Cash and Cash Equivalents 0 0
Current Marketable Securities 197 192
Non-Current Marketable Securities 270 410
Mortgage- and asset-backed securities | Level 2    
Marketable Securities [Line Items]    
Marketable Securities, Debt, Adjusted Cost 24,508 22,365
Marketable Securities, Debt, Unrealized Gains 27 6
Marketable Securities, Debt, Unrealized Losses (2,086) (2,735)
Marketable Securities, Debt, Fair Value 22,449 19,636
Cash and Cash Equivalents 0 0
Current Marketable Securities 1,393 344
Non-Current Marketable Securities $ 21,056 $ 19,292
v3.24.2.u1
Financial Instruments - Non-Current Marketable Debt Securities by Contractual Maturity (Details)
$ in Millions
Jun. 29, 2024
USD ($)
Fair value of non-current marketable debt securities by contractual maturity  
Due after 1 year through 5 years $ 64,209
Due after 5 years through 10 years 8,660
Due after 10 years 18,371
Total fair value $ 91,240
v3.24.2.u1
Financial Instruments - Additional Information (Details) - Vendor
 9 Months Ended 12 Months Ended
Jun. 29, 2024
Sep. 30, 2023
Trade receivables | Credit concentration risk | Cellular network carriers    
Financial Instruments [Line Items]    
Concentration risk, percentage 32.00% 41.00%
Non-trade receivables | Credit concentration risk    
Financial Instruments [Line Items]    
Number of vendors that individually represented 10% or more of total vendor non-trade receivables 2 2
Non-trade receivables | Credit concentration risk | Vendor one    
Financial Instruments [Line Items]    
Concentration risk, percentage 46.00% 48.00%
Non-trade receivables | Credit concentration risk | Vendor two    
Financial Instruments [Line Items]    
Concentration risk, percentage 18.00% 23.00%
Hedges of foreign currency exposure associated with revenue and inventory purchases    
Financial Instruments [Line Items]    
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions 12 months  
Hedges of foreign currency exposure associated with term debt    
Financial Instruments [Line Items]    
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions 18 years  
v3.24.2.u1
Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($)
$ in Millions
Jun. 29, 2024
Sep. 30, 2023
Derivatives designated as accounting hedges | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount $ 65,542 $ 74,730
Derivatives designated as accounting hedges | Interest rate contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount 13,875 19,375
Derivatives not designated as accounting hedges | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Derivatives, notional amount $ 97,136 $ 104,777
v3.24.2.u1
Financial Instruments - Derivative Instruments Designated as Fair Value Hedges and Related Hedged Items (Details) - USD ($)
$ in Millions
Jun. 29, 2024
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Carrying amount of hedged marketable securities $ 15,007 $ 14,433
Hedged asset, statement of financial position [Extensible Enumeration] Marketable securities, Marketable securities Marketable securities, Marketable securities
Carrying amount of hedged term debt $ (13,096) $ (18,247)
Hedged liability, statement of financial position [Extensible Enumeration] Term debt, Term debt Term debt, Term debt
v3.24.2.u1
Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Jun. 29, 2024
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Gross property, plant and equipment $ 117,129 $ 114,599
Accumulated depreciation (72,627) (70,884)
Total property, plant and equipment, net $ 44,502 $ 43,715
v3.24.2.u1
Income Taxes - Additional Information (Details)
Aug. 30, 2016
Subsidiary
Unfavorable investigation outcome, EU State Aid rules  
Income Tax Contingency [Line Items]  
Number of subsidiaries impacted by the European Commission tax ruling 2
v3.24.2.u1
Debt - Additional Information (Details) - USD ($)
$ in Millions
Jun. 29, 2024
Sep. 30, 2023
Debt Instrument [Line Items]    
Commercial paper $ 2,994 $ 5,985
Fixed-rate notes, aggregate carrying amount 98,300 105,100
Commercial paper    
Debt Instrument [Line Items]    
Commercial paper 3,000 6,000
Level 2    
Debt Instrument [Line Items]    
Fixed-rate notes, aggregate fair value $ 86,200 $ 90,800
v3.24.2.u1
Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($)
$ in Millions
 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Maturities 90 days or less:    
Repayments of commercial paper, net $ (2,985) $ (3,326)
Maturities greater than 90 days:    
Repayments of commercial paper 0 (2,645)
Total repayments of commercial paper, net $ (2,985) $ (5,971)
v3.24.2.u1
Shareholders' Equity - Additional Information (Details)
shares in Millions, $ in Billions
 9 Months Ended
Jun. 29, 2024
USD ($)
shares
Stockholders' Equity Note [Abstract]  
Number of shares repurchased (in shares) | shares 387
Amount of share repurchases | $ $ 70.0
v3.24.2.u1
Share-Based Compensation - Restricted Stock Unit Activity and Related Information (Details) - Restricted stock units
$ / shares in Units, shares in Thousands, $ in Millions
 9 Months Ended
Jun. 29, 2024
USD ($)
$ / shares
shares
Number of Restricted Stock Units  
Beginning balance (in shares) | shares 180,247
RSUs granted (in shares) | shares 78,276
RSUs vested (in shares) | shares (83,842)
RSUs canceled (in shares) | shares (8,258)
Ending balance (in shares) | shares 166,423
Weighted-Average Grant Date Fair Value Per RSU  
Beginning balance (in dollars per share) | $ / shares $ 135.91
RSUs granted (in dollars per share) | $ / shares 172.26
RSUs vested (in dollars per share) | $ / shares 126.47
RSUs canceled (in dollars per share) | $ / shares 137.85
Ending balance (in dollars per share) | $ / shares $ 157.66
Aggregate Fair Value  
Aggregate fair value of RSUs | $ $ 35,052
v3.24.2.u1
Share-Based Compensation - Additional Information (Details) - Restricted stock units - USD ($)
$ in Billions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of RSUs as of the respective vesting dates $ 6.4 $ 7.0 $ 15.0 $ 14.9
Total unrecognized compensation cost related to RSUs $ 21.9   $ 21.9  
Total unrecognized compensation cost related to RSUs, weighted-average recognition period     2 years 7 months 6 days  
v3.24.2.u1
Share-Based Compensation - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Share-Based Payment Arrangement [Abstract]        
Share-based compensation expense $ 2,869 $ 2,617 $ 8,830 $ 8,208
Income tax benefit related to share-based compensation expense $ (764) $ (993) $ (2,662) $ (2,791)
v3.24.2.u1
Segment Information and Geographic Data - Information by Reportable Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Segment Reporting Information [Line Items]        
Net sales $ 85,777 $ 81,797 $ 296,105 $ 293,787
Operating income 25,352 22,998 93,625 87,332
Americas        
Segment Reporting Information [Line Items]        
Net sales 37,678 35,383 125,381 122,445
Operating income 15,209 13,117 50,640 44,908
Europe        
Segment Reporting Information [Line Items]        
Net sales 21,884 20,205 76,404 71,831
Operating income 9,170 7,995 31,872 27,380
Greater China        
Segment Reporting Information [Line Items]        
Net sales 14,728 15,758 51,919 57,475
Operating income 5,562 6,207 20,884 24,175
Japan        
Segment Reporting Information [Line Items]        
Net sales 5,097 4,821 19,126 18,752
Operating income 2,544 2,443 9,498 9,073
Rest of Asia Pacific        
Segment Reporting Information [Line Items]        
Net sales 6,390 5,630 23,275 23,284
Operating income $ 2,610 $ 2,328 $ 9,995 $ 9,447
v3.24.2.u1
Segment Information and Geographic Data - Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Operating income $ 25,352 $ 22,998 $ 93,625 $ 87,332
Research and development expense (8,006) (7,442) (23,605) (22,608)
Operating segments        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Operating income 35,095 32,090 122,889 114,983
Segment reconciling items        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Research and development expense (8,006) (7,442) (23,605) (22,608)
Corporate non-segment        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Other corporate expenses, net $ (1,737) $ (1,650) $ (5,659) $ (5,043)